Literature DB >> 9135027

An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis.

R Choudhuri1, H T Zhang, S Donnini, M Ziche, R Bicknell.   

Abstract

Recent analysis of bladder tumors has correlated expression of the neurokine midkine (MK) with poor patient survival. To examine a role for MK and the related pleiotrophin (PTN) in tumorigenesis, they were overexpressed in MCF-7 breast carcinoma cells. Expression had no effect on in vitro growth but conferred a growth advantage in vivo. Enhanced tumor growth correlated with increased vascular density and endothelial proliferation, implicating an angiogenic role for MK and PTN. Angiogenic activity of MK and PTN was confirmed in the rabbit corneal assay. Our data therefore identify two novel targets for antiangiogenic drug development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135027

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  80 in total

1.  Nuclear targeting by the growth factor midkine.

Authors:  Yoshihisa Shibata; Takashi Muramatsu; Makoto Hirai; Tatsuya Inui; Terutoshi Kimura; Hidehiko Saito; Lynn M McCormick; Guojun Bu; Kenji Kadomatsu
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 2.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

3.  Construction of a fusion protein expression vector MK-EGFP and its subcellular localization in different carcinoma cell lines.

Authors:  Li-Cheng Dai; Di-Yong Xu; Xing Yao; Li-Shan Min; Ning Zhao; Bo-Ying Xu; Zheng-Ping Xu; Yong-Liang Lu
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

4.  Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.

Authors:  Marius Grzelinski; Florian Steinberg; Tobias Martens; Frank Czubayko; Katrin Lamszus; Achim Aigner
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

Review 5.  Therapeutic potential of midkine in cardiovascular disease.

Authors:  Kenji Kadomatsu; Péter Bencsik; Anikó Görbe; Csaba Csonka; Kazuma Sakamoto; Satoshi Kishida; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

6.  Expression and purification of bioactive high-purity human midkine in Escherichia coli.

Authors:  Zhong-hui Zhang; Li-juan Du; Di Xiang; Shun-ying Zhu; Ming-yuan Wu; Hui-li Lu; Yan Yu; Wei Han
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

7.  Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.

Authors:  Yunchao Chang; Masahiko Zuka; Pablo Perez-Pinera; Aurora Astudillo; Joanne Mortimer; James R Berenson; Thomas F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

8.  Embryological Origin of Human Smooth Muscle Cells Influences Their Ability to Support Endothelial Network Formation.

Authors:  Johannes Bargehr; Lucinda Low; Christine Cheung; William G Bernard; Dharini Iyer; Martin R Bennett; Laure Gambardella; Sanjay Sinha
Journal:  Stem Cells Transl Med       Date:  2016-05-18       Impact factor: 6.940

9.  Nucleolin: acharan sulfate-binding protein on the surface of cancer cells.

Authors:  Eun Ji Joo; Gerdy B ten Dam; Toin H van Kuppevelt; Toshihiko Toida; Robert J Linhardt; Yeong Shik Kim
Journal:  Glycobiology       Date:  2004-08-25       Impact factor: 4.313

10.  Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasis.

Authors:  Zoi Diamantopoulou; Paraskevi Kitsou; Suzanne Menashi; Jose Courty; Panagiotis Katsoris
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.